Engineering stem cells to produce exosomes with enhanced bone regeneration effects: an alternative strategy for gene therapy.

In this strategy, engineered MSCs function as cellular factories, which effectively produce exosomes with designed and enhanced therapeutic effects. The accelerating effect in bone healing and the good biocompatibility suggest the potential clinical application of this strategy.